Imidazopyrazines as protein kinase inhibitors

Details for Australian Patent Application No. 2006315718 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Dwyer, Michael P.; Curran, Patrick J.; Tadikonda, Praveen K.; Belanger, David B.; Paruch, Kamil; Guzi, Timothy. J.; Zhao, Lianyun; Siddiqui, M. Arshad; Hamann, Blake; Reddy, Panduranga A.

Agent Griffith Hack

Pub. Number AU-B-2006315718

PCT Pub. Number WO2007/058942

Priority 60/735,982 10.11.05 US

Filing date 8 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 4 October 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 35/00 Antineoplastic agents

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/058942 Priority application(s): WO2007/058942

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Application Accepted

  Published as AU-B-2006315718

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315734-Method and apparatus for compacting sail cars

2006315715-Identification of USA300 community-associated methicillin-resistant staphylococcus aureus